Xofluza 80 mg, Filmtabletten - Swissmedic Key 67426005 Registration Holder Roche Pharma (Schweiz) AG Name Xofluza 80 mg, Filmtabletten Date of registration 19.02.2020 Introduction of Sequence 30.08.2022 ATC-Classification Baloxavir Marboxil (J05AX25) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) Show package size Index Therapeuticus (Swissmedic) 08.03. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information CI Deductible k.A. Feedback FB GTIN 7680674260059 Medication Code Synthetika Pharmacode Disponibility
Composition baloxavirum marboxilum 80 mg, lactosum monohydricum 311.6 mg, carmellosum natricum conexum, povidonum K 25, cellulosum microcristallinum, natrii stearylis fumaras, talcum, Überzug: hypromellosum, talcum, titanii dioxidum, pro compresso obducto corresp. natrium 2.3 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Baloxavirum Marboxilum 80 mg
Inactive agents Dose additional_information Carmellosum Natricum Conexum Cellulosum Microcristallinum Hypromellosum Überzug Lactose Monohydrate 311.6 mg Natrii Stearylis Fumaras Povidonum K 25 Pro Compresso Obducto Talcum Titanium Dioxide
Source Data was imported : 19.11.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
